To accurately quantify the DNA methylation differences between normal and tumor tissues, to evaluate the performance of different CTCF-binding sites in discriminating tumor tissues from normal tissues, the methylation state of the 23 tumor-specific CTCF-binding sites identified by MS-HRM analysis was further determined by mass spectrometry analysis in 20 pairs of normal and tumor tissues. Here, CTCF is linked to neoplasm.